Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Ullem Insider Profile
11 Followers
Scott Ullem, CVP, CFO at Edwards Lifesciences, holds 1.67K shares in Illumina (Ticker: ILMN), holds 285.39K shares in Edwards Lifesciences (Ticker: EW), holds 4.73K shares in Berry Global Group (Ticker: BERY).
Scott Ullem has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Ullem holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Scott Ullem
Scott Ullem's Trading History
Edwards Lifesciences
Apr 01, 2024
CVP, CFO
Uninformative Sell
688.39K
$24.67M
Berry Global Group
Nov 28, 2023
Director
Uninformative Buy
―
$269.73K
Illumina
Apr 02, 2024
Director
Uninformative Buy
22.44K
$204.21K
Bemis Company
Oct 08, 2013
―
Uninformative Buy
439.00K
$1.33M
List of latest transactions for each holding click on a transaction to see Scott Ullem's performance on stock
You May Also Like
Scott Ullem insider profile FAQ
What is the percentage of profitable transactions made by Scott Ullem?
The percentage of profitable transactions made by Scott Ullem is ―.
What is the average return per transaction made by Scott Ullem?
The average return per transaction made by Scott Ullem is ―.
What stocks does Scott Ullem hold?
Scott Ullem holds: EW, BERY, ILMN, BMS stocks.
What was Scott Ullem’s latest transaction?
Scott Ullem latest transaction was an Uninformative Buy of $22.44K.
What was Scott Ullem's most profitable transaction?
Scott Ullem’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Scott Ullem's role in Edwards Lifesciences?
Scott Ullem's role in Edwards Lifesciences is CVP, CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.